Rebecca Clancy

Q: What is Rebecca Clancy email address?

Email Rebecca Clancy at ryebecca@aol.com and rclancy@jaguargenetherapy.com. This email is the most updated Rebecca Clancy email found in 2026.

Q: How to contact Rebecca Clancy?

To contact Rebecca Clancy send an email to ryebecca@aol.com or rclancy@jaguargenetherapy.com. (updated on October 29, 2024)

Senior Director Quality and Regulatory Affairs at Jaguar Gene Therapy | United States

About Rebecca Clancy

Rebecca Clancy is a seasoned professional with over 22 years of extensive experience in GxP (Good Practice) quality and compliance oversight, specifically within the pharmaceutical and biotech sectors. As the Director of Preclinical Quality at Jaguar Gene Therapy, Rebecca plays a pivotal role in ensuring that preclinical programs adhere to the highest standards of GLP (Good Laboratory Practice), GCP (Good Clinical Practice), and GMP (Good Manufacturing Practice). Her expertise spans a diverse range of products, including gene therapies, medical devices, combination products, small molecules, biologics, and inhaled pharmaceuticals.

In her current role, Rebecca is responsible for the day-to-day quality and compliance oversight of preclinical programs. She collaborates closely with functional leads across various departments to ensure seamless end-to-end cGxP compliance, fostering a culture of quality that permeates both preclinical and clinical spaces. Her leadership in developing and implementing new phase-appropriate quality systems and procedures is crucial for maintaining alignment with current site policies and regulatory requirements, including 21 CFR Part 11.

Rebecca's proficiency in quality review processes, change control, and laboratory information management systems (LIMS) enables her to effectively manage complex projects while ensuring compliance with industry regulations. Her strong communication skills, combined with her ability to lead cross-functional teams, make her an invaluable asset to Jaguar Gene Therapy as the organization advances its innovative gene therapy solutions. Through her commitment to quality and compliance, Rebecca not only safeguards the integrity of preclinical programs but also contributes to the overall success and reputation of the company in the competitive biotech landscape.

Rebecca Clancy Work